Retinal Degeneration 3 (RD3) (N-Term) Peptide
RD3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all RD3 products
- RD3 (Retinal Degeneration 3 (RD3))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RD3 antibody (Catalog #: ARP55856_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RD3 (Retinal Degeneration 3 (RD3))
- Synonyms
- C1orf36 Peptide, LCA12 Peptide, 3322402L07Rik Peptide, rd-3 Peptide, rd3 Peptide, retinal degeneration 3 Peptide, RD3 Peptide, Rd3 Peptide
- Background
-
RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
Alias Symbols: C1orf36, LCA12
Protein Size: 195 - Molecular Weight
- 23 kDa
- Gene ID
- 343035
- NCBI Accession
- NM_183059, NP_898882
- UniProt
- Q7Z3Z2
-
You are here:
